| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 321,078 | 296,005 | 209,535 | 379,089 | | Cost of Revenue | 278,532 | 256,820 | 201,437 | 670,924 | | | Gross Profit | 42,546 | 39,185 | 8,098 | (291,835) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 45,004 | 49,546 | 48,859 | 72,603 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,458) | (10,361) | (40,761) | (364,438) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,801) | 4,452 |
-
| (47,839) | | Earnings Before Interest And Taxes | (11,133) | (11,368) | (37,672) | (433,489) | | Interest Expense | 12,633 | 11,735 | 11,041 | 10,336 | | Income Before Tax | (23,766) | (23,103) | (48,713) | (443,825) | | Income Tax Expense | 33 | 10 | 255 | (47,525) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (23,799) | (23,113) | (48,968) | (396,300) | | | Non-recurring Events | | Discontinued Operations | (45) | (20) | (504) | (281) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (23,844) | (23,133) | (49,472) | (396,581) | | Preferred Stock And Other Adjustments | 14,449 | 14,179 | 30,394 | 299,985 | | | Net Income Applicable To Common Shares | ($9,395) | ($8,954) | ($19,078) | ($96,596) |
|
0.31% Nasdaq 0.00%
Income Statement
